ArticleBMC nephrology2026
Revisiting the death of Louis XIV: a nephrological perspective.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment - Louis XIV's terminal illness clinical chronology favors necrotizing soft-tissue infection.BMC nephrology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLouis XIV died in 1715 at the age of 76 years. His death was attributed by contemporaneous accounts to dry gangrene secondary to peripheral arterial disease. Several clinical features described in these accounts may also be interpreted through alternative modern nephrological frameworks, including chronic kidney disease and calciphylaxis.
methodsWe performed a critical reappraisal of contemporaneous medical and lay descriptions of King's terminal illness, integrating these sources with contemporary knowledge of chronic kidney disease and calciphylaxis. The work followed a hypothesis-driven approach, explicitly acknowledging the inherent limitations of retrospective diagnosis in historical medicine.
resultsHistorical descriptions report progressive, painful ischemic lesions of the lower limb evolving toward necrosis and death from sepsis. Louis XIV presented several conditions currently recognized as calciphylaxis risk factors, including obesity, diabetes mellitus, and possibly chronic kidney disease. When examined through a modern nephrological perspective, features such as a 10-day delay between pain onset and lesion appearance, lesion localization, pain severity, and the absence of traumatic origin are compatible with calciphylaxis.
conclusionBased on a critical reinterpretation of contemporaneous accounts and modern pathophysiological knowledge, this work explores the possibility that Louis XIV's terminal illness is compatible with chronic kidney disease and calciphylaxis. Although retrospective confirmation is impossible, calciphylaxis remains a plausible hypothesis, highlighting the potential under-recognition of chronic kidney disease and its complications in historical cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.